首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   4168篇
  免费   541篇
  国内免费   38篇
耳鼻咽喉   11篇
儿科学   160篇
妇产科学   64篇
基础医学   168篇
口腔科学   71篇
临床医学   1016篇
内科学   1209篇
皮肤病学   221篇
神经病学   542篇
特种医学   322篇
外科学   458篇
综合类   37篇
预防医学   165篇
眼科学   56篇
药学   58篇
  1篇
肿瘤学   188篇
  2023年   71篇
  2021年   51篇
  2020年   77篇
  2019年   33篇
  2018年   99篇
  2017年   115篇
  2016年   116篇
  2015年   155篇
  2014年   177篇
  2013年   225篇
  2012年   95篇
  2011年   118篇
  2010年   226篇
  2009年   285篇
  2008年   142篇
  2007年   88篇
  2006年   114篇
  2005年   65篇
  2004年   47篇
  2003年   66篇
  2002年   61篇
  2001年   85篇
  2000年   48篇
  1999年   86篇
  1998年   151篇
  1997年   200篇
  1996年   169篇
  1995年   160篇
  1994年   126篇
  1993年   130篇
  1992年   86篇
  1991年   65篇
  1990年   44篇
  1989年   83篇
  1988年   82篇
  1987年   63篇
  1986年   51篇
  1985年   52篇
  1984年   43篇
  1983年   41篇
  1982年   46篇
  1981年   30篇
  1980年   53篇
  1978年   36篇
  1977年   23篇
  1976年   23篇
  1975年   25篇
  1973年   23篇
  1960年   21篇
  1954年   20篇
排序方式: 共有4747条查询结果,搜索用时 187 毫秒
101.
102.
103.
104.
105.
The evolution of autonomous units of organized human society from tribes to sovereign nation‐states has been paralleled by a belief in a need for global unification under a religious or secular authority.

A modern alternative to the subordination of nation‐state sovereignty to a higher authority is to restrain the excesses of the established world system by institutionalizing in the United Nations a democratic voice for the world public's opinions. This could be done by means of: (1) a UN Second ('we the peoples') Assembly or related proposal; (2) a UN Parliamentary Assembly to represent national parliaments; (3) an assembly representative of non‐governmental organizations affiliated with the UN or its Agencies and other bodies; (4) a UN‐grassroots system for information‐sharing and dispute‐solving.

The paper summarizes the principles of these approaches, and outlines in more detail the multidisciplinary basis of the concept of a UN Second Assembly, the Penrose method for equitable voting power or distribution of seats in a world assembly, and the work of the International Network for a UN Second Assembly (INFUSA) including the initiative for a series of international Conferences on A More Democratic United Nations (CAMDUN).  相似文献   
106.
Objectives : To determine the 3 year safety and efficacy of crush‐stenting with paclitaxel‐eluting stents. Background : The optimum two‐stent strategy for treatment of coronary bifurcation lesions is undetermined. Crush‐stenting is advocated to minimize restenosis through complete circumferential stent coverage; long‐term follow‐up data are lacking. Methods and Results : In a single center prospective registry, 100 consecutive patients with bifurcation lesions were treated with the Crush technique. The vast majority (93%) were true bifurcations, predominantly involving the left anterior descending and diagonal arteries. Technical success was 98%. Final kissing balloon dilatation, which became standard practice during the study, was attempted in 68 patients and successful in 51. Abciximab was used in all cases. There were no peri‐procedural stent thromboses. Follow‐up was 100% at 3 years. Symptom‐driven target lesion revascularisation was 8% at 3 years. Cumulative 3‐year major adverse cardiac events was 28% (7 cardiac deaths, 15 myocardial infarctions, 11 target vessel revascularisations). Absence of a final kissing inflation predicted repeat revascularisation but not death, infarction or stent thrombosis. Three probable stent thromboses occurred, of which two were very late. Conclusion : Where a two‐stent bifurcation strategy is required, Crush‐stenting with paclitaxel‐eluting stents is safe and effective in the long‐term. Failure to perform a final kissing dilatation increases the likelihood of revascularisation but not other adverse events. © 2009 Wiley‐Liss, Inc.  相似文献   
107.
108.
Rosai–Dorfman disease (RDD) is a rare entity of non‐Langerhans cell histiocytoses (non‐LCH) which usually presents with bilateral painless cervical lymphadenopathy. We describe a neonate with RDD who presented with anemia, thrombocytopenia and hepatomegaly. He recovered spontaneously with conservative management. This represents an atypical presentation of RDD. Conservative management with close monitoring can be adopted for some with systemic involvement. Pediatr Blood Cancer 2009;52:415–417. © 2008 Wiley‐Liss, Inc.  相似文献   
109.
110.
Abstract Thirty consecutive patients with bleeding oesophageal varices secondary to schistosomal liver disease received injection sclerotherapy. These formed a part of a prospective study, to evaluate the role of sclerotherapy in the treatment of bleeding oesophageal varices due to different aetiological factors in patients seen at the Gastroenterology Unit, Riyadh Armed Forces Hospital, Saudi Arabia, between December 1980 and July 1984.
Schistosomiasis is endemic in parts of Saudi Arabia. Sclerotherapy has a special place in schistosomal liver disease as liver function is well preserved in this disease. The new antischistosomal drugs are effective and may halt the progress of the disease. However, in many patients portal hypertension with bleeding oesophageal varices is found at diagnosis. Of the patients with schistosomiasis, 63.3% were Group A Child's Classification. Oesophageal varices have been eradicated in 11 cases during the mean follow-up period of 28 months (range 3-44 months). Four patients were referred for surgery because of bleeding gastric varices, two of whom died following operation. One patient, who was also hepatitis B surface antigen positive, died due to re-bleeding from gastric varices. The remaining 25 patients had no recurrence of bleeding and their liver function remained satisfactory.
Surgical procedures for oesophageal varices in schistosomiasis carry the risk of peri-operative and postoperative morbidity and mortality. In contrast, complications following sclerotherapy are minor compared to surgical procedures and none of our patients had any serious sclerotherapy complications.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号